CytomX Therapeutics, Inc 10-K for FY2020
CytomX Therapeutics, Inc. (CTMX)
10-K
2021-02-24
For: 2020-12-31
View Original
Added on
April 09, 2026
About this 10-K
CytomX Therapeutics, Inc filed this 10-K on February 24, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $100.36M
- up 74.6% from $57.49M a year earlier
- Net loss
- $32.89M
- compared with a net loss of $102.24M a year earlier